These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 937064)

  • 21. Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest?
    Van Biesen W; Lameire N; Verbeke F; Vanholder R
    J Nephrol; 2008; 21(3):299-304. PubMed ID: 18587717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peritoneal dialysis in chronic renal insufficiency].
    Taraba I
    Ter Arkh; 1985; 57(6):91-4. PubMed ID: 4071421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Home peritoneal dialysis during infancy.
    Lorentz WB; Hamilton RW; Disher B; Crater C
    Clin Nephrol; 1981 Apr; 15(4):194-7. PubMed ID: 7237866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of protein and peptide fractions from the peritoneal dialysate of patients with chronic renal failure on the lipoprotein lipase activity.
    Lutz W
    Acta Med Pol; 1979; 20(2):131-41. PubMed ID: 532698
    [No Abstract]   [Full Text] [Related]  

  • 25. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dialysis treatment of chronic renal failure].
    Thieler H
    Zentralbl Chir; 1993; 118(3):118-21. PubMed ID: 8484283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal replacement therapy utilizing hemodialysis and peritoneal dialysis.
    Paganini EP; Vidt DG
    Urol Clin North Am; 1983 May; 10(2):347-67. PubMed ID: 6344391
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of intraperitoneal furosemide administration on levels of +proteins+ in plasma and signs of their ability to be dialyzed during intermittent peritoneal dialysis].
    Grzegorzewska A; Krzymański M; Antoniewicz K
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):67-70. PubMed ID: 1845696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual renal function, peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis.
    Heimbürger O
    Kidney Int Suppl; 1996 Nov; 56():S47-55. PubMed ID: 8914054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phagocytic activity of neutrophils from the peritoneal dialysate of patients with chronic renal failure treated by intermittent peritoneal dialysis.
    Sułowicz W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):325-30. PubMed ID: 1697837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of peritoneal dialysis in renal replacement therapy: an update on medical aspects.
    Yao Q; Wang X; Chung SH; Pecoits-Filho R; Stenvinkel P; Wang T; Heimbürger O; Lindholm B
    Panminerva Med; 2005 Mar; 47(1):19-30. PubMed ID: 15985974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Levels of plasma proteins in patients with ene stage renal failure treated with peritoneal dialysis with an addition of furosemide to dialysis fluid].
    Grzegorzewska A; Krzymański M; Antoniewicz K
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):137-40. PubMed ID: 8090666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chronic kidney failure in diabetics with peritoneal dialysis].
    Bednárová V; Sulková S
    Cas Lek Cesk; 1996 May; 135(11):340-3. PubMed ID: 8706069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination of peritoneal dialysis and hemodialysis in the treatment of chronic renal insufficiency].
    Makó J; Karátson A; Szöllösi G; Boros G; Solt I; Méhes M; Brasch H; Sámik J
    Orv Hetil; 1989 Sep; 130(39):2083-6. PubMed ID: 2677908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with the artificial kidney (dialysis).
    Farrell PC; Stewart JH
    Med J Aust; 1976 Feb; 1(6):160-5. PubMed ID: 1263970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytomorphological, cytochemical and functional characteristics of cells from peritoneal dialysates of patients with terminal renal failure treated by peritoneal dialysis. V. Functional studies--the phagocytic activity].
    Sułowicz W
    Przegl Lek; 1987; 44(11):751-6. PubMed ID: 3447242
    [No Abstract]   [Full Text] [Related]  

  • 38. Peroxidase activity in peritoneal neutrophils of patients with terminal renal failure treated by intermittent peritoneal dialysis.
    Sułowicz W; Hanicki Z; Labza H; Basta A
    Med Interne; 1990; 28(2):135-8. PubMed ID: 2176739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal dialysis in chronic renal failure in children: a six year study.
    Santos F; Harford AM; Mendez-Picon G; Chan JC
    Int J Pediatr Nephrol; 1987; 8(1):45-50. PubMed ID: 3583557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disorders of protein and lipid metabolism associated with chronic renal failure and chronic dialysis.
    Krumlovsky FA
    Ann Clin Lab Sci; 1981; 11(4):350-60. PubMed ID: 7023349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.